Castle Biosciences CSTL Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| NET REVENUES by Product | |||||
| Dermatologic | $216.37M-15.8% | $257M+40.2% | $183.37M+46.9% | $124.81M+45.5% | |
| Non-Dermatologic | $127.86M+70.3% | $75.07M+106% | $36.42M+198% | $12.23M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Castle Biosciences break its business down?
- Castle Biosciences (CSTL) reports net revenues by product across 2 parts — Dermatologic and Non-Dermatologic. Each is extracted from the segment footnotes and tracked over time.
- Where does Castle Biosciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Castle Biosciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
